Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v34-EN Version v1-EN
Language English English
Date Updated 2024-02-14 2022-09-16
Drug Identification Number 02329204 02329204
Brand name TARO-CEFPROZIL TARO-CEFPROZIL
Common or Proper name CEFPROZIL CEFPROZIL
Company Name SUN PHARMA CANADA INC SUN PHARMA CANADA INC
Ingredients CEFPROZIL CEFPROZIL
Strength(s) 125MG 125MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code J01DC J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-07-26 2022-07-26
Estimated end date 2023-08-18 2022-09-23
Actual end date 2023-08-21
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments